Darwin Global Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.58B Sell
16,805,184
-4,128,093
-20% -$635M 68.33% 1
2025
Q4
$3.64B Buy
20,933,277
+475,832
+2% +$86.8M 73.78% 1
2025
Q3
$2.9B Buy
20,457,445
+1,112,824
+6% +$136M 80.54% 1
2025
Q2
$1.92B Buy
19,344,621
+3,946,646
+26% +$302M 80.75% 1
2025
Q1
$1.2B Buy
15,397,975
+2,437,437
+19% +$186M 82.08% 1
2024
Q4
$895M Buy
12,960,538
+2,463,261
+23% +$177M 84.75% 1
2024
Q3
$766M Buy
10,497,277
+6,956,182
+196% +$513M 62.31% 1
2024
Q2
$237M Buy
+3,541,095
New +$137M 27.58% 2

Other funds holding INSM

Darwin Global Management's INSM Position: Q1 2026 in Review

Darwin Global Management reduced its Insmed (INSM) stake by 20% in Q1 2026, selling an estimated $635M and leaving 16,805,184 shares worth $2.58B. The position accounts for 68.33% of the portfolio, ranked #1.

Darwin Global Management first reported a position in INSM in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.64B in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Darwin Global Management held 16,805,184 shares of Insmed worth $2.58B as of Q1 2026.
  • Darwin Global Management sold 4,128,093 Insmed shares in Q1 2026, an estimated $635M.
  • Insmed made up 68.33% of Darwin Global Management's portfolio in Q1 2026, its #1 holding.
  • Darwin Global Management first reported a position in Insmed in Q2 2024 and has held it in 8 quarters since.
  • Darwin Global Management's Insmed position peaked at $3.64B in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Darwin Global Management's 13F filing for Q1 2026, filed 15 May 2026.